However, those cells that were cotransfected with the miR-203a-3p inhibitor and ATM siRNA showed no significant differences when compared to nontransfected cells in terms of those indicators, suggesting that miR-203a-3p can target ATM to mediate the Akt/GSK-3β/Snail signaling pathway in ovarian cancer. Here, ATM is linked to ovarian cancer.